RE:Investor attitude toward managementI think many of the investors here are well beyond frustrated. For those who originally owned ABCANN which became VIVO, which was absorbed into Medipharm, we have seen management time and time again ensure their own benefit/prosperity before the shareholders. Even now the senior management positions command a compensation well above the industry average for similar sized companies. For most of us our investment is now only worth 1 - 2 cents on the dollar of what was initially invested so probably not worth selling and similarily probably never going to be worth much more than we are seeing right now. Simply Wall Street has their free cashflow at -11.3 million and senior management compensation (or at least what they can estimate as a 4 of the 8 senior management positions are currenly listed as "no data") is in excess of 6.7 million.
That suggests that the likelihood of shareholders seeing any increase in equity is rather slim at the moment.
But hey - maybe they will all take a pay cut for the good of the company.
GLTA
Rusty